Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial—the ‘DEXAPAE’ study

INTRODUCTION: Postembolisation syndrome (PES) is the most common side effect of vascular embolisation of solid organs. Although prophylactic corticosteroids are known to reduce the incidence and severity of PES, no trials investigating their efficacy have been conducted in men undergoing prostatic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Svarc, Petra, Stroomberg, Hein Vincent, Juhl Jensen, Ruben, Frevert, Susanne, Håkan Lindh, Mats, Taudorf, Mikkel, Brasso, Klaus, Lönn, Lars, Røder, Martin Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Radiology and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562514/
https://www.ncbi.nlm.nih.gov/pubmed/34725072
http://dx.doi.org/10.1136/bmjopen-2020-047878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562514/
https://www.ncbi.nlm.nih.gov/pubmed/34725072
http://dx.doi.org/10.1136/bmjopen-2020-047878

Ejemplares similares